Table 3. Univariate and multivariate analyses of predictors of survival for the HCC patients with extrahepatic metastasis.
Variables | Hazard Ratio | 95% CI | P value |
Univariate analysis | |||
Sex (Male vs. Female) | 1.137 | 0.630∼2.053 | 0.669 |
Age (≤48 vs. >48 years) | 1.098 | 0.681∼1.772 | 0.701 |
PS(0∼1 vs. 2∼4) | 1.876 | 0.793∼2.638 | 0.132 |
Serum albumin (≤35 vs. >35 g/L) | 0.745 | 0.539∼1.563 | 0.401 |
Total bilirubin(≤21 vs. >21 µmol/L) | 1.683 | 0.997∼2.843 | 0.051 |
Prothrombin time (≤12.8 vs. >12.8 s) | 1.659 | 1.026∼2.682 | 0.039 |
AFP level (≤400 vs. >400 ng/mL) | 1.047 | 0.620∼1.767 | 0.864 |
Child–Pugh grade(A vs. B,C) | 2.019 | 1.165∼3.498 | 0.012 |
Portal/hepatic vein invasion(Yes vs. No) | 1.724 | 1.016∼2.437 | 0.042 |
CLIP Score(0∼3 vs. 4∼6) | 1.129 | 0.768∼2.139 | 0.568 |
Site (lymph node vs. others)* | 1.671 | 1.018∼2.703 | 0.036 |
Site (bone vs. others)* | 0.894 | 0.507∼1.575 | 0.697 |
Site (lung vs. others)* | 1.001 | 0.563∼1.779 | 0.998 |
Multivariate analysis | |||
Site (lymph node vs. others)* | 1.878 | 1.025∼3.161 | 0.040 |
*Site: site of extrahepatic metastases.